Drug Shortage Report for ZYPREXA INTRAMUSCULAR
| Report ID | 259698 |
| Drug Identification Number | 02247099 |
| Brand name | ZYPREXA INTRAMUSCULAR |
| Common or Proper name | OLANZAPINE |
| Company Name | CHEPLAPHARM REGISTRATION GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | OLANZAPINE |
| Strength(s) | 10MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | single use vial containing 10 mg olanzapine |
| ATC code | N05AH |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-04-25 |
| Estimated end date | 2025-07-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-06-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | WEILER STRASSE 5E LÖRRACH, GERMANY 79540 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-06-05 | French | Compare |
| v1 | 2025-06-05 | English | Compare |
Showing 1 to 2 of 2